Single-molecule nanopore dielectrophoretic trapping of α-synuclein with lipid membranes
Source abstract
Abstract
The lipid-α-Synuclein (α-Syn) interaction plays a crucial role in the pathogenesis of Parkinson’s disease. Here, we investigate the lipid-binding and -unbinding kinetics of α-Syn in an α-hemolysin (αHL) single nanopore. Under an applied voltage, an engineered α-Syn sequence can be trapped at the nanopore due to the dielectrophoretic force. The conformational switch events of α-Syn can be observed at the pore-membrane junction through the interpretation of blockade current amplitudes and dwell time. This allows further analysis of α-Syn conformational dynamics. We study how disease-associated metal ions (Cu2+, Zn2+) modulate the dynamics of α-Syn at the interface of the membranes and pore and how α-helical peptidomimetics stabilize the helical conformation of α-Syn in a lipidic environment. These studies aid our understanding of the complexity of the interaction of α-Syn, lipid membranes, and metal ions, and in using peptidomimetics, a new strategy against α-Syn toxicity and aggregation is advanced.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nanopore and Nanochannel Transport Studies · Lipid Membrane Structure and Behavior · Microfluidic and Capillary Electrophoresis Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (69)
Show source-provided references
1. Identification of two distinct synucleins from human brain10.1016/0014-5793(94)00395-5 ↗
2. Stabilization of α-synuclein secondary structure upon binding to synthetic membranes10.1074/jbc.273.16.9443 ↗
3. Refolding of helical soluble α-synuclein through transient interaction with lipid interfaces10.1002/1873-3468.13047 ↗
4. Conformational properties of α-synuclein in its free and lipid-associated states10.1006/jmbi.2001.4538 ↗
5. Investigation of α-synuclein fibril structure by site-directed spin labeling10.1074/jbc.M700368200 ↗
6. Structural intermediates during α-synuclein fibrillogenesis on phospholipid vesicles10.1021/ja209019s ↗
7. Interaction of human α-synuclein and Parkinson's disease variants with phospholipids: structural analysis using site-directed mutagenesis10.1074/jbc.M004851200 ↗
8. Membrane binding of oligomeric α-synuclein depends on bilayer charge and packing10.1016/j.febslet.2008.10.009 ↗
9. Interaction of α-synuclein with biomembranes in Parkinson's disease—role of cardiolipin10.1016/j.plipres.2015.10.005 ↗
10. Alpha-synuclein lipid-dependent membrane binding and translocation through the α-hemolysin channel10.1016/j.bpj.2013.12.028 ↗
11. An extracellular mechanism that can explain the neurotoxic effects of α-synuclein aggregates in the brain10.3389/fphys.2012.00297 ↗
12. Cryo-electron microscopy imaging of Alzheimer's amyloid-beta 42 oligomer displayed on a functionally and structurally relevant scaffold10.1002/anie.202104497 ↗
13. Single-molecule studies of amyloid proteins: from biophysical properties to diagnostic perspectives10.1017/S0033583520000086 ↗
14. Clustering of α-synuclein on supported lipid bilayers: role of anionic lipid, protein, and divalent ion concentration10.1016/j.bpj.2008.10.011 ↗
15. The role of lipids in α-synuclein misfolding and neurotoxicity10.1074/jbc.REV119.007500 ↗
16. Effects of curvature and composition on α-synuclein binding to lipid vesicles10.1016/j.bpj.2010.07.056 ↗
17. α-Synuclein senses lipid packing defects and induces lateral expansion of lipids leading to membrane remodeling10.1074/jbc.M113.478297 ↗
18. Definition of a molecular pathway mediating α-synuclein neurotoxicity10.1523/JNEUROSCI.4650-14.2015 ↗
19. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers10.1111/jnc.13772 ↗
20. Patterns of levels of biological metals in CSF differ among neurodegenerative diseases10.1016/j.jns.2011.01.003 ↗
21. Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease10.1111/j.1471-4159.1989.tb07264.x ↗
22. Metals in Alzheimer's and Parkinson's diseases10.1016/j.cbpa.2008.02.019 ↗
23. Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease10.1089/ars.2015.6343 ↗
24. Interaction of α-synuclein with divalent metal ions reveals key differences: a link between structure, binding specificity and fibrillation enhancement10.1021/ja0618649 ↗
25. Alpha-synuclein oligomers interact with metal ions to induce oxidative stress and neuronal death in Parkinson's disease10.1089/ars.2015.6343 ↗
26. Structural characterization of copper (II) binding to α-synuclein: insights into the bioinorganic chemistry of Parkinson's disease10.1073/pnas.0407881102 ↗
27. Nanopore-based, rapid characterization of individual amyloid particles in solution: concepts, challenges, and prospects10.1002/smll.201802412 ↗
28. Nanopore analysis of β-amyloid peptide aggregation transition induced by small molecules10.1021/ac1029874 ↗
29. Analysis of a single α-synuclein fibrillation by the interaction with a protein nanopore10.1021/ac401496x ↗
30. Probing of various physiologically relevant metals: amyloid-β peptide interactions with a lipid membrane-immobilized protein nanopore10.1007/s00232-014-9662-z ↗
31. Interactions of peptides with a protein pore10.1529/biophysj.104.057406 ↗
32. Protein nanopore-based, single-molecule exploration of copper binding to an antimicrobial-derived, histidine-containing chimera peptide10.1021/la303782d ↗
33. Structure of staphylococcal alpha-hemolysin, a heptameric transmembrane pore10.1126/science.274.5294.1859 ↗
34. Interplay of α-synuclein binding and conformational switching probed by single-molecule fluorescence10.1073/pnas.0809232106 ↗
35. Cu(II) and dopamine bind to α-synuclein and cause large conformational changes10.1111/febs.12817 ↗
36. Protein co-translocational unfolding depends on the direction of pulling10.1038/ncomms5841 ↗
37. Multistep protein unfolding during nanopore translocation10.1038/nnano.2013.22 ↗
38. Electrokinetic particle entry into microchannels10.1002/elps.201100484 ↗
39. The many faces of α-synuclein: from structure and toxicity to therapeutic target10.1038/nrn3406 ↗
40. Stabilization of alpha-synuclein secondary structure upon binding to synthetic membranes10.1074/jbc.273.16.9443 ↗
41. Amphipathic helical cationic antimicrobial peptides promote rapid formation of crystalline states in the presence of phosphatidylglycerol: lipid clustering in anionic membranes10.1016/j.bpj.2010.03.002 ↗
42. Lipid topology and electrostatic interactions underpin lytic activity of linear cationic antimicrobial peptides in membranes10.1073/pnas.1704489114 ↗
43. Interaction and structure induction of cell-penetrating peptides in the presence of phospholipid vesicles10.1016/S0005-2736(01)00304-2 ↗
44. The enhanced membrane interaction and perturbation of a cell penetrating peptide in the presence of anionic lipids: toward an understanding of its selectivity for cancer cells10.1016/j.bbamem.2013.02.008 ↗
45. A molecular view on the interaction of the trojan peptide penetratin with the polar interface of lipid bilayers10.1529/biophysj.103.034025 ↗
46. Anionic phospholipid interactions with the potassium channel KcsA: simulation studies10.1529/biophysj.105.071407 ↗
47. Single-molecule site-specific detection of protein phosphorylation with a nanopore10.1038/nbt.2799 ↗
48. Enhanced translocation of single DNA molecules through alpha-hemolysin nanopores by manipulation of internal charge10.1073/pnas.0808296105 ↗
49. Intrinsic and membrane-facilitated α-synuclein oligomerization revealed by label-free detection through solid-state nanopores10.1038/srep20776 ↗
50. Nanopore analysis of β-amyloid peptide aggregation transition induced by small molecules10.1021/ac1029874 ↗
51. Cryo-electron Microscopy Imaging of Alzheimer’s Amyloid-beta 42 Oligomer Displayed on a Functionally and Structurally Relevant Scaffold10.1002/anie.202104497 ↗
52. Stefureac · Biochem. Cell. Biol. · 2010 · 88 · 34710.1139/O09-176 ↗
53. Cu2+ ions modulate the interaction between α-synuclein and lipid membranes10.1016/j.jinorgbio.2022.111945 ↗
54. Transmembrane protein rotaxanes reveal kinetic traps in the refolding of translocated substrates10.1038/s42003-020-0840-5 ↗
55. Single-nucleotide discrimination in immobilized DNA oligonucleotides with a biological nanopore10.1073/pnas.0901054106 ↗
56. Single pyrimidine discrimination during voltage-driven translocation of osmylated oligodeoxynucleotides via the α-hemolysin nanopore10.3762/bjnano.7.11 ↗
57. Lipid bilayer disruption by oligomeric alpha-synuclein depends on bilayer charge and accessibility of the hydrophobic core10.1016/j.bbamem.2009.03.010 ↗
58. The influence of vesicle size and composition on alpha-synuclein structure and stability10.1016/j.bpj.2008.12.3940 ↗
59. α-Synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains10.1016/j.jmb.2007.11.051 ↗
60. Metal ions shape α-synuclein10.1038/s41598-020-73207-9 ↗
61. Rationally designed helical peptidomimetics disrupt alpha–synuclein fibrillation10.1039/D2CC00212D ↗
62. NMR determination of pKa values in α-synuclein10.1002/pro.556 ↗
63. Non-covalent S⋯ O interactions control conformation in a scaffold that disrupts islet amyloid polypeptide fibrillation10.1039/C6SC00756B ↗
64. Dopamine promotes α-synuclein aggregation into SDS-resistant soluble oligomers via a distinct folding pathway10.1096/fj.04-3437fje ↗
65. Dopamine-induced α-synuclein oligomers show self-and cross-propagation properties10.1002/pro.2521 ↗
66. Stabilization of alpha-synuclein oligomers in vitro by the neurotransmitters, dopamine and norepinephrine: the effect of oxidized catecholamines10.1007/s11064-015-1597-y ↗
67. Dopamine induces soluble α-synuclein oligomers and nigrostriatal degeneration10.1038/nn.4641 ↗
68. Electrode-free nanopore sensing by DiffusiOptoPhysiology10.1126/sciadv.aar3309 ↗
69. Planar microelectrode-cavity array for high-resolution and parallel electrical recording of membrane ionic currents10.1039/b800431e ↗